Episode 6: Game-Changing Leadership - Steve Cutler, CEO of ICON plc

In this candid, clear-eyed conversation, Dr. Steve Cutler, CEO of ICON plc, sits down with Patty to reflect on a career that has spanned four continents and helped shape the modern CRO industry. From a series of happy accidents that led a Sydney science graduate into pharmaceutical development, to nearly a decade playing rugby for Australia, Steve shares how resilience and teamwork forged the leader he became. 

You’ll hear Steve and Patty explore how the CRO industry has matured since its founding days, why so few patients still take part in clinical research, and the regulatory and cultural barriers that keep the industry doing things the way it always has. They also consider what might finally push the industry to change, and how AI will reshape the work ahead. This episode explores what it takes to move a famously conservative industry faster, and the persistence required to lead through constant change. 

What you’ll hear about

• How has the CRO industry evolved since its early founding days? 

• Why do so few patients ever take part in clinical trials? 

• Are privacy rules and regulations making clinical research harder than necessary? 

• What will it take to break the industry’s “same old” inertia? 

• What can a sporting career teach you about leading in business? 

• How quickly will AI really transform the way trials are run? 

This episode is intended for clinical operations executives and outsourcing leaders, offering a clear perspective on where the CRO industry is headed and how to prepare for the change ahead. 

Timestamps 

00:05 – An accidental path into clinical research 

03:50 – Why the CRO world offered more room to grow 

05:10 – Learning from the founders as the industry matured 

07:05 – Making life easier for research sites 

09:55 – Making clinical research a care option 

11:35 – What’s really holding patient participation back 

14:20 – Working with regulators to simplify research 

17:00 – Breaking decades of industry inertia 

18:20 – The catalyst the industry may need 

20:10 – Closing the gap between leadership and the front lines 

22:15 – Lessons from the rugby field 

24:40 – Speed, efficiency, and the next decade of clinical trials 

28:30 – The legacy of a leader who gets things done 

Guest Biography 

Dr. Steve Cutler is the CEO of ICON plc, one of the world’s leading clinical research organizations. A Sydney-trained PhD scientist who played rugby for Australia and has worked across four continents, he has spent three decades helping grow CROs into trusted partners to the pharmaceutical industry, including leading ICON through its landmark acquisition of PRA Health Sciences. He is driven by a mission to make clinical research faster, simpler, and a routine care option for far more patients.